Yichen Li
Impact in
-
- Cancer, Hypoxia, and Metabolism
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies
- Clostridium difficile and Clostridium perfringens research
Papers in
-
- Gut microbiota and health 4
- Genetics 9
- Inflammatory Bowel Disease 7
- Co-authors
- Lixin Zhu (12 shared papers)Sijing Cheng (9 shared papers)Ping Lan (8 shared papers)Na Jiao (9 shared papers)Ruixin Zhu (8 shared papers)Dingfeng Wu (4 shared papers)Yifeng Zou (7 shared papers)Daici Chen (4 shared papers)
- Journals
- Oncogene (2 papers)Anti-Cancer Drugs (2 papers)The FASEB Journal (2 papers)Emerging Microbes & Infections (2 papers)Signal Transduction and Targeted Therapy (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Yichen Li
63 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 134
- Cancer Research 136
- Infectious Diseases 158
- Biological Psychiatry 17
- Oncology 184
- Molecular Biology 448
Countries citing papers authored by Yichen Li
This map shows the geographic impact of Yichen Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yichen Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yichen Li more than expected).
Fields of papers citing papers by Yichen Li
This network shows the impact of papers produced by Yichen Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yichen Li. The network helps show where Yichen Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Yichen Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 170 | |
| 2 | 2020 | 121 | |
| 3 | 2021 | 85 | |
| 4 | 2017 | 70 | |
| 5 | 2019 | 55 | |
| 6 | 2018 | 37 | |
| 7 | 2022 | 36 | |
| 8 | 2021 | 36 | |
| 9 | 2022 | 34 | |
| 10 | 2023 | 33 | |
| 11 | 2018 | 31 | |
| 12 | 2020 | 27 | |
| 13 | 2022 | 25 | |
| 14 | 2017 | 24 | |
| 15 | 2016 | 22 | |
| 16 | 2021 | 19 | |
| 17 | 2024 | 19 | |
| 18 | 2024 | 18 | |
| 19 | 2014 | 18 | |
| 20 | 2022 | 18 |
About Yichen Li
Yichen Li is a scholar working on Molecular Biology, Genetics, Oncology, Immunology and Infectious Diseases, having authored 69 papers that have together received 1.1k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (7 papers), Gut microbiota and health (4 papers), COVID-19 Clinical Research Studies (4 papers), Immune cells in cancer (4 papers), Peptidase Inhibition and Analysis (3 papers), Hydrocarbon exploration and reservoir analysis (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Viral Infections and Immunology Research (3 papers). The work is most often cited by research in Cancer Research (136 citations), Infectious Diseases (158 citations), Biological Psychiatry (17 citations), Oncology (184 citations) and Molecular Biology (448 citations). Yichen Li has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Lixin Zhu, Sijing Cheng, Ping Lan, Na Jiao, Ruixin Zhu, Dingfeng Wu, Yifeng Zou, Daici Chen, Jian Cai and Ming‐Liang He. Their work appears in journals such as Oncogene, Anti-Cancer Drugs, The FASEB Journal, Emerging Microbes & Infections and Signal Transduction and Targeted Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.